康心伴Logo
康心伴WellAlly
SGLT2 Inhibitors

Dapagliflozin

通用名:Dapagliflozin | 常用商品名:Farxiga

What is Dapagliflozin?

Dapagliflozin is an SGLT2 inhibitor that lowers blood sugar and offers heart and kidney protection for many people with type 2 diabetes or heart failure.

How it works

It inhibits SGLT2 in the proximal renal tubule, causing glucose to be excreted in urine along with mild natriuresis and diuresis.

Common uses

  • Glycemic control in type 2 diabetes
  • Reducing hospitalizations for heart failure, even without diabetes
  • Slowing decline in chronic kidney disease when eligible

Monitoring & Safety

  • Labs: Monitor glucose, hba1c, and renal labs egfr/creatinine to ensure safe use.
  • Possible side effects include genital yeast infections, urinary frequency, and rare ketoacidosis.

Dosing (简要)

  • Taken once daily, with or without food; doses commonly 5-10 mg.
  • Dose adjustments based on kidney function and indication.

Drug interactions

  • Loop or thiazide diuretics can add to dehydration risk.
  • Insulin or sulfonylureas raise hypoglycemia risk; may need dose changes.

Patient tips

  • Drink enough water unless fluid restricted.
  • Pause the medication during severe illness or before major surgery as instructed.
  • Report symptoms of urinary infection promptly.

When to contact your doctor

  • Severe stomach pain with nausea and high sugars.
  • Dizziness, fainting, or signs of dehydration.
  • Persistent genital itching or discharge.

Medical Disclaimer: 本内容仅供教育用途,不能替代专业医疗建议。

🧪 需重点监测的化验

医生常关注这些指标,以确保 Dapagliflozin 安全有效:

正在服用 Dapagliflozin?

上传你的化验结果,WellAlly 会将 hba1c 趋势与用药时间线一起展示。

⚠️ 医疗免责声明

此处信息仅供教育参考,不构成医疗建议。请咨询医生解读用药与化验结果,勿自行停药。

Dapagliflozin(Dapagliflozin):用途、相互作用与监测 | WellAlly